Screener
Pulse Biosciences, Inc. PLSE Total Cost of Revenue
Discontinued — last reported Q2 '26
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue | $434 | — | $835 | — |
| Cost and expenses: | ||||
| Cost of product revenue | 273 | — | 643 | — |
| Research and development | 16,976 | 12,088 | 29,566 | 22,401 |
| Selling, general and administrative | 8,457 | 8,187 | 15,048 | 15,918 |
| Total cost and expenses | 25,706 | 20,275 | 45,257 | 38,319 |
| Loss from operations | (25,272) | (20,275) | (44,422) | (38,319) |
Document
FAQ
- What is Pulse Biosciences, Inc.'s total cost of revenue?
- Pulse Biosciences, Inc. (PLSE) reported total cost of revenue of $273K in Q2 2026.
- What is the long-term trend for Pulse Biosciences, Inc.'s total cost of revenue?
- Over 2 years (2022 to 2025), Pulse Biosciences, Inc.'s total cost of revenue has grown at a -78.8% compound annual growth rate (CAGR), from $11.94M to $539K.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Pulse Biosciences, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude